Short-term effects of a combined nutraceutical of insulin-sensitivity lipid level and indexes of liver steatosis: a double-blind randomized cross-over clinical trial

摘要

BackgroundOverweight subjects easily develop alterations of the glucose and lipid metabolism and are exposed to an increased cardiometabolic risk. This condition is potentially reversible through the improvement of dietary and behavioural habits. However, a well-assembled nutraceutical would be a useful tool to better improve the metabolic parameters associated to overweight and insulin resistance.